U12-type Spliceosome : Localization and Effects of Splicing Efficiency on Gene Expression by Pessa, Heli
U12-type Spliceosome: Localization and Effects of Splicing
Efficiency on Gene Expression
Heli Pessa
Institute of Biotechnology 
and 
Division of Genetics 
Department of Biosciences 
Faculty of Biological and Environmental Sciences 
and 
Viikki Graduate School in Biosciences 
University of Helsinki
Academic dissertation
To be presented for public examination with the permission of the Faculty of Biological and
Environmental Sciences of the University of Helsinki in Auditorium 1041 in Biocenter 2,
Viikinkaari 5, Helsinki, on 15 October, 2010 at 12 o'clock noon.




Reviewers Docent Marjo Salminen
Department of Basic Veterinary Sciences





Faculty of Biological and Environmental Sciences 
University of Helsinki
Helsinki, Finland
Opponent Professor Marie Öhman
Department of Molecular Biology and Functional Genomics
Stockholm University
Stockholm, Sweden
Custos Professor Tapio Palva
Department of Biosciences





ISBN 978-952-10-6439-5 (PDF, http://ethesis.helsinki.fi)
Cover image: U12 snRNA detected by fluorescent in situ hybridization in mouse NIH-3T3
cell nuclei
Cover layout by Timo Päivärinta
Helsinki University Print, Helsinki 2010
Scientists have one thing in common with children: curiosity. To be a good scientist you must
have kept this trait of childhood, and perhaps it is not easy to retain just one trait.
– Otto Robert Frisch 
Contents
List of original publications
Abbreviations
Abstract
1 Review of the literature............................................................................................................1
1.1 Overview of eukaryotic pre-mRNA processing...............................................................1
1.2 Introns in eukaryotic genes...............................................................................................1
1.2.1 Complex organisms have large variation of intron sizes..........................................1
1.2.2 Introns early or introns late.......................................................................................2
1.2.3 Introns are gained and lost........................................................................................2
1.3 Intron types.......................................................................................................................3
1.3.1 Two types of spliceosomal introns in eukaryotes.....................................................3
1.3.2 U12-type consensus sequences.................................................................................3
1.3.3 U12-type introns may have a regulatory function....................................................4
1.3.4 Non-spliceosomal introns.........................................................................................4
1.4 Splicing signals.................................................................................................................5
1.4.1 Exon definition facilitates intron recognition ..........................................................5
1.4.2 Exonic and intronic sequences influence splice site choice.....................................5
1.5 Alternative splicing..........................................................................................................6
1.5.1 Alternative splicing increases variety in the transcriptome......................................6
1.5.2 Regulation of alternative splicing.............................................................................7
1.5.3 Alternative splicing by the U12-type spliceosome...................................................8
1.5.4 Other forms of regulated splicing.............................................................................8
1.6 Splicing and disease.........................................................................................................8
1.6.1 Aberrant splicing has a role in many diseases..........................................................8
1.6.2 Mutations in spliceosome components may have tissue-specific phenotypes.........9
1.7 Spliceosomal composition..............................................................................................10
1.7.1 Components of the U2-type spliceosome...............................................................10
1.7.2 Components of the U12-type spliceosome.............................................................10
1.7.3 Evolutionary origin of the two spliceosomes.........................................................13
1.8 Biogenesis of spliceosomal snRNPs..............................................................................14
1.8.1 Biogenesis of Sm-class snRNPs.............................................................................14
1.8.2 Biogenesis of U6 and U6atac.................................................................................14
1.9 Spliceosomal catalysis and assembly.............................................................................15
1.9.1 Spliceosomal catalysis............................................................................................15
1.9.2 U2-type spliceosome assembly...............................................................................15
1.9.3 U12-type spliceosome assembly.............................................................................16
1.9.4 Spliceosome recycling............................................................................................17
1.10 Communication with other processing systems...........................................................17
1.10.1 Cotranscriptional splicing.....................................................................................17
1.10.2 mRNA quality control by splicing .......................................................................18
2 Aims of the study...................................................................................................................19
3 Materials and methods...........................................................................................................20
4 Results and discussion...........................................................................................................21
4.1 The abundance of U12-dependent spliceosome components does not limit endogenous
splicing efficiency (I)...........................................................................................................21
4.1.1 U4atac is the limiting component in the formation of U4atac/U6atac complex....21
4.1.2 Low U4atac levels inhibit splicing of a transfected construct................................21
4.1.3 Splicing of endogenous introns is not limited by U4atac levels.............................22
4.1.4 U12-type introns are spliced less efficiently than normal introns..........................22
4.2 Deficient U12-type splicing causes perturbations in metabolic gene expression in
Drosophila (III).....................................................................................................................23
4.2.1 U6atac-deficient larvae die at 3rd larval stage.......................................................23
4.2.2 Genes with a U12-type intron show variable responses to defective splicing.......24
4.2.3 Downstream effects in U12-type splicing mutant may involve a mitochondrial
defect................................................................................................................................25
4.3 U12-dependent spliceosome functions in the nucleus (II).............................................25
4.3.1 The snRNA components of the U12-type spliceosome are localized in the nucleus
.........................................................................................................................................25
4.3.2 Protein and snRNA components of the U12-dependent spliceosome are detected
primarily in nuclear fractions of cells..............................................................................26




List of original publications
This thesis is based on the following articles, which are referred to in the text by their
Roman  numerals.  The  articles  are  reproduced  with  kind  permission  from  the  copyright
owners.
I Pessa, H.K.J., Ruokolainen, A. and Frilander, M.J. (2006) The abundance of the
spliceosomal snRNPs is not limiting the splicing of U12-type introns. RNA 12: 1883-
1892.
I Pessa, H.K.J., Will, C.L., Meng, X., Schneider, C., Watkins, N.J., Perälä, N., Nymark,
M., Turunen, J.J., Lührmann, R. and Frilander, M.J. (2008) Minor spliceosome
components are predominantly localized in the nucleus. Proc. Natl. Acad. Sci. U.S.A.
105: 8655-8660.
II Pessa, H.K.J., Greco, D., Kvist, J., Wahlström, G., Heino, T.I., Auvinen, P. and
Frilander, M.J. Gene expression profiling of U12-type spliceosome mutant
Drosophila reveals widespread changes in metabolic pathways. PloS ONE, in press.
Author's contribution to the publications
I HP performed experiments and participated in data analysis and writing of the
manuscript.
II HP designed and performed part of the experiments, analyzed data and wrote the
manuscript.
III HP designed and performed experiments, analyzed data and wrote the manuscript.
Abbreviations
A Adenine
ASF Alternative splicing factor
ATP Adenosine triphosphate
C Cytosine
EJC Exon junction complex
ESE Exonic splicing enhancer




hnRNP Heterogenous nuclear RNP
ISE Intronic splicing enhancer
ISS Intronic splicing silencer
mRNA Messenger RNA
nt Nucleotide
PCR Polymerase chain reaction
PHB Prohibitin
qRT-PCR Quantitative RT-PCR




RT-PCR Reverse transcription PCR
SF Splicing factor
SMA Spinal muscular atrophy
SMN Survival of motor neurons
snRNA Small nuclear RNA





U2AF U2 auxiliary factor
Abstract
The removal of non-coding sequences, introns, is an essential part of messenger RNA
processing. In most  metazoan organisms,  the U12-type spliceosome processes a subset  of
introns containing highly conserved recognition sequences. U12-type introns constitute less
than 0,5% of all introns and reside preferentially in genes related to information processing
functions, as opposed to genes encoding for metabolic enzymes. It has previously been shown
that  the  excision  of  U12-type  introns  is  inefficient  compared  to  that  of  U2-type  introns,
supporting  the  model  that  these  introns  could  provide  a  rate-limiting  control  for  gene
expression.
In this  work, cells  with  low abundance of the U12-type spliceosome were found to
inefficiently  process  U12-type  introns  encoded  by  a  transfected  construct,  but  with
endogenous  genes,  the  abundance  of  the  U12-type  spliceosome  was  not  found  to  affect
expression  levels.  However,  significant  levels  of  endogenous  unspliced  U12-type  intron-
containing pre-mRNAs were detected in cells. Together these results support the idea that
U12-type splicing may limit gene expression in some situations.
The  effect  of  U12-type  splicing  efficiency  on  a  whole  organism  was  studied  in  a
Drosophila mutant deficient in U12-type splicing. Genes containing U12-type introns showed
variable  gene-specific  responses  to  the  splicing defect.  Surprisingly,  microarray screening
revealed  that  metabolic  genes  were  enriched  among  downstream  effects,  and  that  the
phenotype could largely be attributed to one U12-type intron-containing mitochondrial gene.
Gene expression control by the U12-type spliceosome could thus have widespread effects on
metabolic functions in the organism.
The subcellular localization of the U12-type spliceosome components was studied as a
response to a recent dispute on the localization of the U12-type spliceosome. All components
studied were found to be nuclear indicating that the processing of U12-type introns occurs
within the nucleus, thus clarifying a question central to the field.
Review of the literature
1 Review of the literature
1.1 Overview of eukaryotic pre-mRNA processing
A eukaryotic gene typically consists of several stretches of coding sequence, exons,
separated by non-coding introns (Figure 1). The discontinuous structure of eukaryotic genes
presents a problem for the gene expression machinery:  open reading frames separated by
intronic areas must be joined together to produce a functional messenger RNA (mRNA). This
process, mRNA splicing, is achieved by the spliceosome, a large complex of small nuclear
RNA (snRNA) molecules assembled into small nuclear ribonucleoprotein (snRNP) particles
and numerous auxiliary proteins. Intron recognition and spliceosome assembly are followed
by catalytic reactions that result in the joining of exons and release of the intron. Splicing
occurs  primarily  cotranscriptionally,  and  is  integrated  with  other  pre-mRNA  processing
events  in  the  nucleus,  such  as  capping  and  polyadenylation.  Transcripts  become  mature
mRNAs  through  multiple  processing  steps  prior  to  transport  out  of  the  nucleus  into  the
cytoplasm, where they can be translated, stored or degraded.
1.2 Introns in eukaryotic genes
1.2.1 Complex organisms have large variation of intron sizes
In higher eukaryotes, multiple introns are present in most genes. Mammals in particular
have a surprising variety of intron sizes and numbers per gene. In humans, mean intron length
is 3300 bp, whereas in the fruit fly Drosophila melanogaster, the average length is less than
500 bp  (Lander et al. 2001). An extreme example is provided by the longest human gene,
coding for the muscle-specific protein dystrophin. It spans 2,5 million bases, but its 79 exons
account less than 1% of total length, with the average intron length of 26 000 bases (Pozzoli
et al. 2002). In general, simple eukaryotes have less introns than multicellular organisms, but
the frequency of introns varies in different lineages (reviewed by  Jeffares et al. 2006). In
baker's yeast Saccharomyces cerevisiae, only 4% of genes have introns, usually only one per
gene (Kupfer et al. 2004). Intron size distribution in yeast, from 50 to 1000 nt, is more narrow
than in more complex organisms. 
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Figure 1. Schematic picture of main steps in pre-mRNA
processing. Blue boxes, exons; thin black lines, introns; green
dots, exon junction complex; thick line, nuclear membrane and
pore.
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1.2.2 Introns early or introns late
The origin of the discontinuous structure of eukaryotic genes is unclear. Two alternative
scenarios have been suggested for the introduction of introns into eukaryotic genomes: the
'introns early' and 'introns late' hypotheses (Darnell 1978, Doolittle 1978; for a review, see e.
g. Koonin 2006). According to the former theory, reading frames have never been continuous,
and prokaryotes have lost their introns as their genomes have become more compact. The
'introns late' theory depicts that introns have been inserted into originally continuous genes
throughout eukaryotic evolution. The 'introns early' model, included in the original version of
the 'exon theory' of gene evolution formulated by Gilbert (1987), assumes that in the earliest
living organisms  with protein-coding genes,  each exon was  a separate  gene  coding for  a
distinct protein domain, which allowed proteins to be functional even before the existence of
splicing mechanisms. The development of splicing then led to the formation of longer genes
with several  exons.  As  a consequence,  present-day genomes  should contain an excess  of
phase 0 introns, which are located between codons rather than inserted within a codon. Phase
0 introns are indeed more common in many genomes than phase 1 or 2 introns, but other
explanations  have  been  presented,  such  as  the  preferential  fixation  of  phase  0  introns
(Sverdlov et al. 2003). While some reports have found a correlation between protein domain
boundaries and intron positions, the theory has not received convincing support (Stoltzfus et
al. 1994, de Souza et al. 1996). 
1.2.3 Introns are gained and lost
According to a widely accepted synthesis between different theories on the origin of
introns, intron gain has been extensive in the common eukaryotic ancestor, but loss and gain
of introns have continued later, at different rates in different lineages (Roy and Gilbert 2005).
Ancestral  introns  are  suggested  to  have  arisen  as  the  result  of  the  insertion  of  mobile
elements, such as transposons (Crick 1979, Sharp 1985). Reversibility of the excision of self-
splicing introns has promoted the hypothesis that an excised intron could reinsert into another
mRNA  and  subsequently  be  reverse  transcribed  and  recombined  into  the  genome  by
homologous recombination (Kruger et al. 1982). Reverse splicing of a nuclear intron by the
spliceosome has indeed been demonstrated in vitro (Tseng and Cheng 2008). Introns can be
lost  through homologous  recombination with  a  spliced and reverse-transcribed mRNA or
deletion via nonhomologous recombination (Robertson 1998). The former process is believed
to have lead to the loss of most introns in yeast, causing a biased distribution of the remaining
ones. Since reverse transcription begins at the 3' end, introns close to the 3' end have a greater
chance of being lost, which explains the excess of old introns near the 5' ends of genes in
intron-poor genomes (Sverdlov et al. 2004). The introduction of introns into the ancestor of
eukaryotes has been speculated to have contributed to the development of the nucleus (Martin
and Koonin 2006). In this model, the endosymbiont that gave rise to mitochondria infected its
host with self-splicing introns, which proliferated extensively in the host genome. The nuclear
membrane was then needed to isolate unspliced pre-mRNAs from the translation machinery
until splicing had been completed. However, the order of appearance of eukaryote-specific
traits has not been resolved.
The removal of introns from pre-mRNAs requires a great deal of resources, but introns
also benefit the organism. Alternative splicing is an important way of generating transcript
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variation especially in complex eukaryotes (see 1.5). It has also been suggested, in the 'exon
shuffling' hypothesis, that the discontinuous structure of genes accelerates the evolution of
new  genes  by  combining  exons  in  new  ways  (Tonegawa et  al. 1978,  Gilbert  1978,
Vibranovski et  al. 2005).  The  advantage  of  discontinuous  genes  in  this  model  is  that
recombination inside introns need not be precise to avoid disruption of the coding sequence.
1.3 Intron types
1.3.1 Two types of spliceosomal introns in eukaryotes
Most introns are processed by the canonical U2-type spliceosome. They contain only
short  stretches  of  highly  conserved  sequence;  at  the  splice  sites,  only  the  terminal
dinucleotides GT-AG are 99% conserved. The polypyrimidine tract near the 3' splice site and
the branch point sequence, usually 20-40 nt upstream of the 3' splice site and containing the
branch point nucleotide, almost always an adenosine, show some conservation (Burge et al.
1998, Sheth et al. 2006). Yeast introns have longer conserved sequences at the splice sites and
a weak polypyrimidine tract (Rymond and Rosbash 1985, Fouser and Friesen 1987).
In  the  early  1990s,  a  subset  of  introns  with  long  and  nearly  invariant  consensus
sequences were discovered  (Jackson 1991). Based on their complementarity with the low-
abundance snRNAs U11 and U12, these introns were suggested to depend on a different set of
snRNAs  for  their  splicing  than  the  common  intron  type  (Hall  and  Padgett  1994).  The
hypothesis was later confirmed by mutational and biochemical  analysis  (Hall  and Padgett
1996, Tarn and Steitz 1996a, Tarn and Steitz 1996b). The first minor class introns found had
terminal AT-AC dinucleotides, hence the minor splicing system was originally dubbed AT-
AC splicing.  However,  many minor  class introns  have  conventional  GT-AG termini  (see
1.3.2), and AT-AC introns were renamed U12-dependent after one of the snRNAs required
for their processing  (Dietrich et al. 1997, Sharp and Burge 1997). U12-dependent, or U12-
type,  introns  have  been  found  in  most  multicellular  organisms  with  the  nematode
Caenorrhabditis elegans being the most prominent exception (Burge et al. 1998, Levine and
Durbin 2001, Zhu and Brendel 2003, Sheth et al. 2006, Alioto 2007). Genomic information
from an increasing number of species has allowed the identification of U12-type introns and
spliceosomal  components  also  in  many  simple  eukaryotes,  including  the  nematode
Trichinella spiralis, protists  Acanthamoeba castellanii  and Physarum polycephalum, several
fungal lineages and three species of genus Phytophthora (Russell et al. 2006, Dávila López et
al. 2008).  Many  other  unicellular  organisms,  e.g.  the  yeasts  S.  cerevisiae and
Schizosaccharomyces pombe  are lacking the U12-type system.  Computational  analyses on
intron frequencies have revealed a higher proportion of U12-type introns in more complex
eukaryotes.  In  human  and  mouse,  U12-type  introns  make  up  about  0,36% of  all  introns
whereas  in  the  plant  Arabidopsis  thaliana,  the  proportion of  U12-type  introns  is  0,24%.
Drosophila has only about 20 U12-type introns (Schneider et al. 2004, Sheth et al. 2006, Lin
et al. 2010). The scarcity of U12-type introns is not typical of all insects but is characteristic
of the dipteran group, in which the U12-type spliceosome has apparently undergone a rapid
evolution (Mount et al. 2007, Lin et al. 2010).
3
Review of the literature
1.3.2 U12-type consensus
sequences
The  terminal  dinucleotides  do
not  distinguish  between  major  and
minor  introns,  because  many  U12-
type  introns  have  conventional  GT-
AG termini,  and a  few introns with
AT-AC  termini  are  spliced  by  the
U2-type spliceosome (Dietrich et al.
1997,  Wu  and  Krainer  1997,  Sharp
and Burge 1997). In humans, 70% of
U12-type introns are of  the GT-AG
subtype,  25% belong to the AT-AC
subtype,  and  the  rest  have  non-
canonical  terminal  dinucleotides
(Sheth et al. 2006). U12-type introns
have  longer  conserved  sequences  at
the  5'  splice  site  and  branch  point
than U2-type introns (Figure 2). U12-
type 5' splice site has the consensus
sequence RTATCCTT, where R is a
purine.  U12-type  introns  lack  a
polypyridimine tract,  but  the branch
site  10-20  nucleotides  upstream  of
the  3'  splice  site  has  the  consensus
sequence TCCTTAAC, although the
conservation is less rigid than at the
5'  splice  site  (Figure  2;  Hall  and  Padgett  1994,  Brock et  al. 2008).  A small  number  of
mutations at the 5' splice site and branch point may cause the switching of a U12-type intron
into  U2-type,  but  the  reverse  process  is  highly  unlikely  due  to  the  extent  of  conserved
sequences required by the U12-dependent spliceosome (Burge et al. 1998). There is, however,
one  documented  case  of  U12-type  intron  gain  in  dipteran  insects  (Lin et  al. 2010).  The
tendency  of  U12-type  introns  to  be  converted  into  U2-type  introns  in  evolution  can  be
deduced from several cases in which a normal intron is present in a homologous location in a
related species. C. elegans is believed to have lost U12-type introns and the U12-dependent
spliceosome from its  genome through this  conversion process.  However,  the  locations  of
U12-type introns are more conserved between species than the positions of U2-type introns
(Basu et  al. 2008).  Some  U12-type  intron  locations  are  remarkably  conserved  between
organisms  as  distant  as  human  and  Arabidopsis (Zhu  and  Brendel  2003).  This  amazing
conservation over evolutionary distance has promoted the hypothesis that U12-type introns
have an important function in gene expression.
1.3.3 U12-type introns may have a regulatory function
The reason for the persistent retention of U12-type introns in most metazoan genomes
has been hypothesized to be their  possible function in expression level  control.  U12-type
4
Figure 2. Sequence logos of human U12-type 5' splice
site, branch point and 3' splice site. The height of the letters
indicates the frequency of bases at each position.
Numbering is relative to splice junctions. Frequency logos
were created with the Weblogo program (Crooks et al.
2004, http://weblogo.berkeley.edu) using sequences
downloaded from the U12 database (Alioto 2007). 
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introns are spliced less efficiently than U2-type introns, as indicated by the presence of pre-
mRNAs with unspliced U12-type introns in cells (Patel et al. 2002). In the report by Patel et
al. (2002), conversion of a U12-type intron into U2-type led to a 6- to 8-fold increase in the
expression levels of the reporter protein. The distribution of U12-type introns in the genome is
not entirely random, but minor introns tend to reside in genes that function in 'information
processing'  tasks,  such  as  DNA replication  or  repair,  transcription,  RNA processing  and
translation, rather than in genes coding for metabolic enzymes. In addition, the number of
genes containing two U12-type introns is larger than would be expected if the locations of
U12-type introns were random (Burge et al. 1998; reviewed by Wu and Krainer 1999).
1.3.4 Non-spliceosomal introns
In  addition  to  spliceosomal  introns,  many  organisms  contain  self-splicing  introns
(Kruger et al. 1982). They are found in bacteria and in the organelles of plants, fungi and
protists (see review by Bonen and Vogel 2001). Self-splicing introns are divided in groups I
and II according to their splicing mechanism. Group II introns are excised through reactions
that  resemble  the  splicing  of  introns  by  the  spliceosome:  a  two-step  transesterification
reaction with adenosine as the initiating nucleophile, producing a lariat intron. Self-splicing
introns can catalyze their own removal in vitro, but protein factors are required in vivo. The
intron often contains an open reading frame that encodes for functions required for splicing
and mobility, such as endonuclease and reverse transcriptase, but factors produced by the host
genome are also needed. Self-splicing introns apparently have a common evolutionary history
with retrotransposons.
Some tRNA genes contain introns that are spliced through a mechanism different from
spliceosomal  or  self-splicing  reactions.  The  splicing  of  tRNA  introns  involves  an
endonuclease,  an  RNA  ligase  and  a  phosphotransferase,  and  requires  energy  from  ATP
hydrolysis (reviewed by Abelson et al. 1998).
1.4 Splicing signals
1.4.1 Exon definition facilitates intron recognition 
Most human exons are relatively short, with length distribution peaking around 100 bp
(Lander et  al. 2001),  but introns  can  be  several  kilobases  long  and  contain  sequences
resembling splice sites by chance. Splicing over long introns is facilitated by pairing splice
sites across exons instead. In this 'exon definition' model, recognition of the 5' splice site by
U1 snRNP promotes the formation of a spliceosomal complex upstream of the flanking exon
(Robberson et al. 1990). Consistent with the model, vertebrate exons are usually less than 300
bases  long,  much  shorter  than introns,  and  increasing the  length  of  an  exon inhibits  the
removal of the preceding intron. Furthermore, mutations in a downstream 5' splice site inhibit
splicing at the upstream intron and cause skipping of the exon between (Talerico and Berget
1990). Exon definition interactions are mediated by U1 snRNP, which enhances the binding
of the U2 auxiliary factor 65K subunit (U2AF-65) at the branch point of the upstream intron
(Hoffman and Grabowski 1992). Splicing of the first and last exon is facilitated by the 5' cap
binding  complex  and  the  polyadenylation  machinery,  respectively,  through  interactions
involving U1 snRNP (Niwa and Berget 1991, Wassarman and Steitz 1993, Lewis et al. 1996).
Exon bridging interactions have been detected also between U2- and U12-type spliceosomes
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(Wu and Krainer 1996). In Drosophila, the problem of large introns may be overcome by
recursive splicing at elements that first function as 3' splice sites and then generate 5' splice
sites after ligation with an upstream exon  (Hatton et al. 1998, Burnette et al. 2005).  Short
Drosophila introns are often removed through 'intron definition', in which the splice sites are
paired  across  the  intron.  This  idea  is  supported by findings  that  in  the  fly,  5'  splice  site
mutations cause intron inclusion rather than upstream exon skipping, and increasing the size
of an intron inhibits splicing  (Talerico and Berget 1994). Further support to differences in
intron recognition between evolutionary lineages is provided by a computational analysis by
Lim and Burge (2001), according to which 5' and 3' splice site signals in D. melanogaster and
C. elegans contain enough information for the identification of most short introns. In human
or Arabidopsis thaliana, the information content of splice sites is lower, consistent with the
use  of  exon  definition  mechanism.  The  conserved  5'  splice  site  sequence  in  yeast  can
accurately identify an intron but, due to the short 3' splice site consensus, exact recognition of
the  3'  end  of  the  intron  requires  additional  signals.  In  S.  cerevisiae,  homologues  to
mammalian factors responsible for exon-spanning interactions are mostly missing  (Abovich
and Rosbash 1997). Also in the fission yeast S. pombe, splicing probably occurs exclusively
by intron definition (Romfo et al. 2000).
1.4.2 Exonic and intronic sequences influence splice site choice
Splicing fidelity depends on the accurate recognition of introns. Especially in complex
eukaryotes in which alternative splicing is common, splice sites are too weak and degenerate
to  accurately  identify  intron  boundaries  without  other  signals.  Human  5'  splice  site-like
sequences occur in average about every 300 bases in random sequence (Burge et al. 1999).
Since introns are often much longer, the information content in U2-type splice sites is not
enough to accurately specify intron ends. The long consensus sequences of U12-type 5' splice
site and branch point provide more information for the recognition of splice sites but, due to
the rarity of U12-type introns, the consensus sequences are still insufficient for locating the
introns. Additional signals are provided by exonic splicing enhancers (ESEs) and silencers
(ESSs) within exons and intronic splicing enhancers (ISEs) and silencers (ISSs) in flanking
introns (reviewed by  Wang and Burge 2008). These elements function as binding sites for
factors  that  either  recruit  spliceosome  subunits  to  the  adjacent  splice  sites  or  antagonize
spliceosome  assembly.  Multiple  ESEs  are  commonly  found  in  both  constitutive  and
alternatively  spliced  human  exons  (Fairbrother et  al. 2002).  They  are  usually  bound  by
members  of  the  serine/arginine-rich  (SR)  protein  family,  which  facilitate  spliceosome
formation by protein interactions (see 1.5.2). Also the U12-type spliceosome can respond to
ESEs, and SR proteins are required for the splicing of U12-type introns  (Wu and Krainer
1998, Dietrich et  al. 2001, Hastings and Krainer 2001). ESSs are typically recognized by
members of the heterogenous nuclear RNP (hnRNP) protein class, which inhibit splicing by
various mechanisms.  Intronic splicing regulation elements are  less  well  characterized,  but
they include binding sites for hnRNP proteins and for some tissue-specific splicing factors.
Intronic elements play an important role in alternative splicing  (Sorek and Ast 2003). The
splicing of some U12-type introns is stimulated by the binding of the hnRNP H protein to
intronic G-rich sequences (McNally et al. 2006).
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1.5 Alternative splicing
1.5.1 Alternative splicing increases variety in the transcriptome
Many genes have alternative splicing patterns that result in the production of a variety
of mRNA isoforms from one gene (reviewed by Graveley 2001, Wang and Burge 2008). As a
general  tendency,  in  simple  organisms  only  a  small  proportion of  genes  are  alternatively
spliced,  whereas  in  more  complex  eukaryotes,  alternative  splicing  is  rather  a  rule  than
exception.  More  than 90% of  human genes  are  alternatively  spliced  (Wang et  al. 2008).
Isoform patterns  take  many  forms,  some  of  which  are  depicted  in  Figure  3.  Alternative
splicing events include alternative 5' and 3' splice sites and cassette exons that are included or
skipped in a regulated manner, such as in the mRNA coding for tropomyosine related kinase
B,  a  neurotrophin  receptor  (Luberg et  al. 2010).  Further  variation  can  be  produced  with
alternative exons, one of which will be included in the mRNA, illustrated by the Drosophila
Dscam (Down syndrome cell adhesion molecule) gene. Its mRNA contains several alternative
exons, each of which are chosen from an array of mutually exclusive exons (Schmucker et al.
2000).  Regulated  intron  retention  can  function  as  a  means  of  gene  expression  control
(Mansilla et al. 2005). Alternative patterns can be e. g. cell- or tissue-specific  (Yeo et al.
2004),  developmentally regulated,  such as  the twintron in  Drosophila prospero gene (see
1.5.3), or changed according to environmental cues or internal signals, such as the alternative
splicing of the protein kinase C mRNA in response to insulin signalling (Chalfant et al. 1998).
Alternative isoforms may differ in function, their specificity can be altered by a change of a
few nucleotides, or entire protein domains may be skipped or introduced. The inclusion or
exclusion of regulatory or localization domains may thoroughly change the function of the
protein,  as  in  the  production  of  soluble  versus  membrane-anchored  variants  of  the  Fas
receptor that have opposing effects on apoptosis  (Cascino et al. 1995). Alternative splicing
does not only induce changes in the coding information, but it may also serve as a regulatory
point in gene expression through changes in sequences that affect mRNA stability. In some
cases,  gene  expression  can  be  regulated  by  the  production  of  splicing  isoforms  with  a
premature stop codon that targets the transcript
for  the  nonsense-mediated  decay  pathway
(Lewis et al. 2003; see also 1.10.2). Examples
of  such  level  regulation  are  the  alternative
splicing  events  on  the  mRNAs  of  U11/U12-
48K  and  65K  proteins. The  former  case
involves  the  creation  of  a  premature  stop
codon, whereas the latter produces two mRNA
isoforms  with  different  half-lives  (Verbeeren
et al. 2010). The levels of several other core
spliceosomal proteins are similarly controlled
by nonsense-mediated decay  (Saltzman et  al.
2008).
1.5.2 Regulation of alternative splicing
Use  of  alternative  splice  sites  is
influenced  by  the  competition  between  SR
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Figure 3. Examples of alternative splicing
patterns. White boxes, exons; grey boxes,
alternative exonic sequences; black lines, splicing
patterns. A. Constitutive splicing. B. Alternative 5'
and 3' splice sites. C. Exon skipping. D. Intron
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proteins and hnRNP proteins, the former having a predominantly enhancing role, whereas the
latter  are  usually  inhibitory.  Members  of  the  SR protein family  share  common structural
features, including the arginine/serine-rich (RS) domain and at least one RNA recognition
motif  (Zahler et al. 1992; reviewed by  Graveley 2000). Other proteins with an RS domain,
many of which function in splicing, are nominated SR-like proteins. The SR protein SF2/ASF
(splicing factor  2/alternative splicing factor)  and hnRNP A1 are examples  of  antagonistic
splicing factors (Mayeda and Krainer 1992). SR protein binding sites are found in most exons
and are often required also for constitutive splicing. In addition to factors binding to splicing
enhancers and repressors, the polypyrimidine tract binding protein, also known as hnRNP I, is
implicated in the repression of alternative exons (García-Blanco et  al. 1989; reviewed by
Valcárcel  and  Gebauer  1997).  In  addition  to  ubiquitous  splicing  regulators,  many tissue-
specific alternative factors have been found, e. g. the neuronal splicing factor Nova (Jensen et
al. 2000) and Fox1 that  functions in both brain and muscle  tissue  (Jin et  al. 2003).  The
additive effects of different regulatory elements and the factors binding to them determine the
splicing pattern of the mRNA (see e. g.  Han et al. 2005). Through this competitive action,
weak splice sites can be used or ignored.
Alternative splicing events have been studied on the whole transcriptome level using
microarrays with exon, exon junction or tiling probes (Johnson et al. 2003, Pan et al. 2004,
Castle et al. 2008; reviewed by Hallegger et al. 2010). Array-based methods are limited to
relatively abundant mRNA species and tend to miss rare events. Recently, high-throughput
sequencing has become an attractive method of detecting alternative splicing (Wang et al.
2008, Richard et al. 2010). Attempts have been made to assemble a general splicing code that
could be used to predict alternative splicing events based on sequence (Barash et al. 2010).
The  task  is  complicated  by  the  redundancy  and  complexity  of  the  elements  and  factors
enhancing and inhibiting splice site recognition.
Alternative splicing can also be regulated by chromatin modifications, and inversely,
gene structure can influence chromatin packaging. Nucleosome density has been found to
differ between introns and exons (Spies et al. 2009, Chen et al. 2010). Histone modifications
can  affect  alternative  splicing  by  influencing  the  speed  of  the  RNA  polymerase  or  the
recruitment of splicing factors to the nascent pre-mRNA (Schor et al. 2009, Luco et al. 2010).
1.5.3 Alternative splicing by the U12-type spliceosome
Alternative splicing patterns rarely involve U12-type introns, most probably because of
the  longer  and  more  rigid  splicing  consensus  sequences  required  by  the  U12-type
spliceosome. Also, the co-operative intron recognition by the U11/U12 di-snRNP (see 1.9.3)
reduces flexibility in splice site recognition.  Use of alternative 3'  splice sites in U12-type
introns has been observed, but the question whether they represent true alternative splicing or
errors has not been resolved (Levine and Durbin 2001, Zhu and Brendel 2003). In some cases,
an intron can be spliced by either the U2- or the U12-type spliceosome at slightly differing
splice sites. The Drosophila gene prospero contains a double intron, 'twintron', consisting of a
U2-type intron nested inside a U12-type one  (Hall and Padgett 1994). The splicing of the
twintron is regulated by a purine-rich element, which binds Drosophila homologues of hnRNP
A1, Hrp38 and Hrp36 proteins, influencing the function of the U2-type and, to a lesser degree,
the U12-type spliceosome (Scamborova et al. 2004, Borah et al. 2009). In some cases a U12-
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type intron is retained in a considerable proportion of the mRNA pool (I). Whether intron
retention is the consequence of splicing regulation or just a side-effect of the low efficiency of
the U12-dependent spliceosome is unclear. Generally, U12-type introns have an effect on the
expression levels rather than on the content of the mRNAs they reside in. 
1.5.4 Other forms of regulated splicing
Trans-splicing forms yet another way of creating variation to the transcriptome. This
means of combining exons in different mRNA molecules was first described in trypanosomes,
where a capped leader sequence is joined to the 5' end of transcripts, and in plant organelles
(reviewed  by  Bonen  1993).  Trans-splicing  events  have  since  been  reported  to  occur
infrequently also in some nuclear mRNAs in animals (Dorn et al. 2001).
Regulation of the level of splicing efficiency is rare, but in yeast, the splicing of several
pre-mRNAs  encoding  for  ribosomal  proteins  is  inhibited  as  a  response  to  amino  acid
starvation (Pleiss et al. 2007).
1.6 Splicing and disease
1.6.1 Aberrant splicing has a role in many diseases
Aberrant splicing can play an important role in disease (for review, see  Faustino and
Cooper 2003, Wang and Cooper 2007). Mutations that cause splicing defects can be divided
in three categories. First,  cis-acting mutations may arise in splicing consensus sequences or
splicing  enhancers  or  inhibitors.  In  a  mutation  analysis  performed  on  the  cystic  fibrosis
transmembrane conductance regulator gene, about one quarter of synonymous mutations in
exons caused exon skipping (Pagani et al. 2005). It has been estimated that more than half of
known disease-causing mutations disrupt splicing (López-Bigas et al. 2005). Second,  trans-
acting mutations may affect  the activity  of  factors  required for  constitutive or  alternative
splicing. Third, the function of common spliceosome components can be impaired (see 1.6.2).
The first two types of mutations cause erroneous splicing that may result in the inappropriate
exclusion of part of the coding sequence, the inclusion of ectopic residues in the polypeptide
produced, or the introduction of a premature stop codon. A change in splicing isoform ratios
may also have serious effects. Abnormal ratios of alternative isoforms of the tau protein cause
its aggregation and play a role in a variety of human neurodegenerative disorders such as
Alzheimer's disease (reviewed by  Liu and Gong 2008). Therapeutic approaches have been
made to  correct  splicing mutations  using e.  g.  modified  oligonucleotides  to  mask cryptic
splice sites (Garcia-Blanco et al. 2004). Ratios of splicing variants can also be used as tools
for  diagnostics,  e.  g.  to monitor  drug efficacy in Alzheimer's  disease  (Darreh-Shori et  al.
2004).
Splicing abnormalities are common in cancer. The SR protein ASF/SF2 is upregulated
in many cancers and promotes the production of oncogenic isoforms of the ribosomal protein
S6 kinase-β1 and the Ron protooncogene (Ghigna et al. 2005, Karni et al. 2007). Alternative
splicing  has  implications  for  the  severity  and  prognosis  of  cancer,  and  cancer-specific
transcripts can serve as biomarkers and diagnostic tools (Dutertre et al. 2010).
1.6.2 Mutations in spliceosome components may have tissue-specific phenotypes
Diseases  associated  with  mutations  in  core  spliceosome  components  do  not  always
result  in  pleiotrophic  effects  but  may  elicit  tissue-specific  phenotypes.  Mutations  in  the
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spliceosomal  PRP31,  PRP3  and  PRP8  proteins,  all  components  of  the  U4/U6.U5  (and
U4atac/U6atac.U5) snRNP complex, cause retinitis pigmentosa, a disease characterized by
retinal  degeneration  and  ultimately  blindness  (McKie et  al. 2001,  Vithana et  al. 2001,
Chakarova et al. 2002, Makarova et al. 2002). The underlying reason for the tissue-specificity
of  symptoms  caused  by  a  mutation  in  a  common  splicing  factor  is  unknown.  Possible
explanations include a requirement of high levels of one or a few mRNAs in the affected
tissue, or the sensitivity of tissue-specific genes to any change in the stoichiometry of splicing
factors (Faustino and Cooper 2003).
Spinal muscular atrophy (SMA), one the most common genetic causes of childhood
lethality,  is  caused by mutations in  the  gene encoding for  the survival  of  motor  neurons
(SMN) protein  (Lefebvre et al. 1995; for review, see Burghes and Beattie 2009). SMA is
caused by the loss of spinal cord motor neurons and results in progressive muscle weakness
and paralysis. SMN has an essential function in the biogenesis of spliceosomal snRNPs in
facilitating the binding of the Sm protein complex to snRNAs (Fischer et al. 1997; see 1.7.1,
1.8.1).  SMN  deficiency  causes  a  reduction  in  the  levels  of  spliceosomal  snRNPs  and,
interestingly, has a stronger effect on minor snRNPs, particularly U11  (Bühler et al. 1999,
Gabanella et al. 2007). SMA patients have splicing defects, but the sequence of pathological
events associated with SMA has not yet been deciphered (Zhang et al. 2008). In the absence
of SMN, Sm proteins can bind inappropriate  RNAs,  which may contribute to the disease
(Pellizzoni et al. 2002).
1.7 Spliceosomal composition
1.7.1 Components of the U2-type spliceosome
The core components of the U2-type spliceosome are for the most part conserved from
yeast to human. The major splicing pathway involves five snRNAs, U1, U2, U4, U5 and U6,
assembled into snRNPs that are named after the snRNAs (Hodnett and Busch 1968, Reddy et
al. 1974, Lerner and Steitz 1979, Krämer et al. 1984, Krainer and Maniatis 1985, Black et al.
1985, Chabot et al. 1985, Black and Steitz 1986). U1, U2, U4 and U5 contain a conserved
uridine-rich sequence flanked by stem loops, the Sm site,  that  is bound by the seven Sm
proteins B/B', D1, D2, D3, E, F and G (Branlant et al. 1982, Liautard et al. 1982, Bringmann
and Lührmann 1986, Lehmeier et al. 1990). Besides the common Sm proteins, each snRNP
contains its own specific proteins. U6 snRNP does not contain Sm proteins but is instead
assembled with the Sm-like proteins Lsm2-8  (Séraphin 1995, Salgado-Garrido et al. 1999,
Achsel et al. 1999). The spliceosomal core proteins are summarized in Table 1.
A number of DExD/H box proteins, many of which possess ATPase and RNA helicase
activity, such as the U5-200K and U5-100K proteins, provide energy for the conformational
changes required for spliceosome formation (see 1.9.2; reviewed by Staley and Guthrie 1998).
The yeast orthologue of U5-100K, Prp28p, has been implicated in disrupting the interaction
between U1 snRNA and the 5′ splice site (Teigelkamp et al. 1997, Staley and Guthrie 1999).
Brr2p/U5-200K may be involved in disrupting the U4/U6 base pairing  (Laggerbauer et al.
1998, Raghunathan and Guthrie 1998b).  Other snRNP-specific proteins include a putative
GTPase, the ribosomal elongation factor 2-like U5-116K protein (Fabrizio et al. 1997). The
single U6-specific protein p110/SART3 (Prp24 in yeast)  is  a recycling factor  involved in
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restoring the base pairing between U4 and U6 (Raghunathan and Guthrie 1998a, Bell et al.
2002).
In  addition  to  Sm and  snRNP-specific  proteins,  numerous  non-snRNP proteins  are
involved in  splicing.  These include RNA binding proteins that  facilitate  the formation of
RNA-RNA interactions, such as U2AF-65 that anneals U2 with the branch point sequence
(Valcárcel et al. 1996). Up to about 300 different proteins have been identified by purification
and mass spectrometry sequencing of spliceosomal complexes at different stages of splicing,
making the spliceosome the largest intracellular machine (Hartmuth et al. 2002, Jurica et al.
2002, Rappsilber et al. 2002, Zhou et al. 2002, Deckert et al. 2006; reviewed by Jurica and
Moore 2003). However, the identification of true splicing factors from other RNA-binding
proteins is not straightforward. Due to the importance of splicing enhancers to the processing
of mRNA in higher eukaryotes, the splicing of many pre-mRNAs is likely to require auxiliary
proteins binding to exonic and intronic splicing enhancers in addition to the spliceosome core
factors. Given the degeneracy of the U2-type splicing consensus sequences, additional factors
may be more numerous in the case of U2-type than U12-type introns. Some protein factors
associated with the spliceosome are involved in communication with other steps in mRNA
maturation, such as the transcription complex, capping and polyadenylation machinery and
the exon junction complex (EJC; see 1.10).
1.7.2 Components of the U12-type spliceosome
The overall  composition  of  the  U12-dependent  spliceosome  is  similar  to  the  major
spliceosome. The snRNAs U1, U2, U4 and U6 are replaced by their functional analogues
U11, U12, U4atac and U6atac, respectively, whereas U5 is shared between the two systems
(Montzka and Steitz 1988, Hall and Padgett 1994, Tarn et al. 1995, Hall and Padgett 1996,
Tarn and Steitz 1996a, Tarn and Steitz 1996b,  note a corrected U4atac/U6atac secondary
structure in Padgett and Shukla 2002). The snRNAs specific to the U12-type spliceosome are
structurally similar to and share some sequence features with their major counterparts (Figure
4). The corresponding snRNPs U11, U12 and U4atac contain the Sm protein complex, and
U6atac is assembled with the Lsm proteins. Similar to U4 and U6, U4atac and U6atac interact
by base pairing and associate with U5 to form the minor tri-snRNP U4atac/U6atac.U5. Unlike
U1 and U2, which exist mainly as monoparticles, U11 and U12 form a di-snRNP through
protein-protein interactions (Wassarman and Steitz 1992b). The U11/U12 di-snRNP lacks U1-
specific proteins but contains most proteins present in U2 snRNP, such as the SF3b complex
(see Table 1). In addition, U11/U12 snRNP contains seven unique proteins not found in the
U2-dependent  spliceosome,  designated 65K,  59K,  48K,  35K, 31K,  25K,  and 20K,  all  of
which are essential for cell viability (Will et al. 1999, Will et al. 2004). 59K, 48K, 35K and
25K are detected also in U11 monoparticles. 65K binds U12 snRNA and U11-59K protein,
thus bridging U11 and U12 snRNPs (Benecke et al. 2005). Based on homology to U1-70K,
35K is believed to function in 5' splice site recognition (Will et al. 1999). 48K protein binds
the 5' splice site transiently at the intron recognition stage, interacts with U11-associated 59K
and has a  role in U11/U12 di-snRNP stability  (Turunen et  al. 2008,  Tidow et  al. 2009).
Furthermore, 59K protein (also known as ES18), has been implicated in apoptosis according
to Park et al. (1999), but in their study it was assumed to be a transcription factor. In contrast
to  the  U11/U12  di-snRNP,  the  protein  components  of  the  U6atac/U4atac.U5  tri-snRNP
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apparently do not differ from those in the major tri-snRNP (Luo et al. 1999, Nottrott et al.
2002, Schneider et al. 2002).
U12-type spliceosome components are about 100 times less abundant than those of the
U2-type spliceosome (Montzka and Steitz 1988, Tarn and Steitz 1996a). Due to the large
number of U snRNA pseudogenes and the difficulty of sequencing tandemly repeated short
genes, the exact number of functional snRNA genes is not known. The copy number estimates
12
Figure 4. Predicted schematic secondary structures of human spliceosomal snRNAs. The Sm
complex binding site is marked with grey shading. The structures of U1, U2, U4, U5 and U6 after Yu
et al. (1999), U11 and U12 after Tarn and Steitz (1997), U4atac and U6atac after Padgett and Shukla
(2002).
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of U2-type spliceosome snRNA genes range from a few to several tens of copies, whereas
minor spliceosome snRNAs are encoded by single-copy genes in most organisms (Lander et
al. 2001, Marz et al. 2008). The expression of different major snRNA variants changes during
development, but the significance of the variants is poorly understood (Forbes et al. 1984,
Lund et al. 1985, Hanley and Schuler 1991, Domitrovich and Kunkel 2003).
Spliceosomal  composition  is  highly  conserved  among  eukaryotes  and  especially  in
multicellular  organisms,  but  some differences are  eminent.  Drosophila  has  orthologues to
most  human  spliceosomal  components,  and the  dynamics  of  entry  and  release  of  factors
during  spliceosome  assembly  and  splicing  reactions  appear  conserved  between  fly  and
vertebrates (Mount and Salz 2000, Herold et  al. 2009). The fly U11 snRNA is markedly
diverged  on  sequence  level,  with  only  28% similarity  to  human  U11,  but  similarities  in
secondary structure and complementarity to the 5' splice site suggest conservation of function
(Schneider et  al. 2004).  Also the U11/U12 proteins 65K and 20K are highly diverged in
Drosophila,  and  homologues  to  U11-specific  proteins  have  not  been  found.  However,
homologues to U11-35K protein have been found in other insects (Will et al. 2004).
Table 1. Human spliceosomal snRNP proteins.
snRNP Shared proteins Spliceosome-specific
proteins
U1 Sm proteins1 U1-70K, U1-A, U1-C
U2 Sm proteins1, SF3b2 SF3a2, U2-A', U2-B''
U5 Sm proteins1, U5-220, 200,
116, 102, 100, 52, 40, 15K 
-
U4/U6, U4atac/U6atac Sm proteins1, Lsm2-8, U4/U6-








U11/U12 Sm proteins1, SF3b2 365K, 59K, 48K, 35K, 31K,
25K, 20K
After Burge et al. (1999), Will et al. (1999), Schneider et al. (2002), Will et al. (2004)
1Sm proteins B/B', D1, D2, D3, E, F and G
2Multi-subunit complexes
1.7.3 Evolutionary origin of the two spliceosomes
The origins of the two parallel splicing systems remain elusive, and several hypotheses
have been presented.  The overall  similarities  in the  composition of  the spliceosomes,  the
secondary structures and functions of the snRNAs and the large number of shared proteins
suggest a common origin. The endosymbiont theory postulates that a unicellular ancestor of
eukaryotes, already in possession of introns and a spliceosome, split into two lineages which
continued  to  diverge,  accumulating  differences  in  spliceosomal  components  and  intron
consensus  sequences  (Burge et  al. 1998).  Later,  these  two  lineages  fused,  possibly  by
endosymbiosis,  to give rise to the ancestor of present-day eukaryotes. Another hypothesis
suggests  that  the  two  spliceosomes  have  developed  through  parallel  evolution  after
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duplication  (Tarn and Steitz 1997). In the latter case, U12-type introns should be randomly
distributed in  the  genome.  Instead,  they tend to  reside in  genes  with functions  related to
information processing, with an overrepresentation of genes that have two U12-type introns.
The endosymbiont theory seems to provide a more plausible explanation to the similarities
and  differences  between  the  two  spliceosomal  systems.  During  the  separation  of  the
spliceosomes, the snRNAs may have evolved faster than proteins, because their functionality
is  more  dependent  on  secondary  structure  than  actual  sequence.  After  fusion,  many  less
diverged  components  would  then  have  been  replaced  by  their  counterparts  in  the  other
spliceosome. All the proteins found so far that are specific to the U12-type spliceosome are
constituents of the U11/U12 di-snRNP, implying that the major differences between the two
systems occur at the intron recognition step (see 1.9.3).
1.8 Biogenesis of spliceosomal snRNPs
1.8.1 Biogenesis of Sm-class snRNPs
In multicellular organisms, spliceosomal snRNPs transiently localize in the cytoplasm
during  their  biogenesis  (reviewed  by  Will  and  Lührmann  2001,  Patel  and  Bellini  2008).
Factors required for the nuclear export of snRNAs or the re-import of snRNPs have not been
found in S. cerevisiae, suggesting that snRNP biogenesis is entirely nuclear in yeast (Huber et
al. 1998, Ohno et al. 2000). The snRNPs of the U12-type spliceosome are believed to follow
the same maturation path as their counterparts in the major spliceosome.
After transcription by the RNA polymerase II, the Sm-class snRNAs U1, U2, U4 and
U5 acquire a monomethylated cap and are exported from the nucleus. Export requires the
monomethyl cap structure and is mediated by the export adapter PHAX specific to U snRNAs
(Hamm and Mattaj 1990, Ohno et al. 2000). In the cytoplasm, the seven Sm proteins are
assembled onto the Sm site. In metazoa, the assembly of the Sm protein ring is facilitated by
the SMN complex consisting of the SMN protein, seven Gemin proteins (Gemins 2-8) and
several other factors (Pellizzoni et al. 2002). After the Sm core assembly, the cap is modified
into a 2,2,7-tri-methyl-guanosine (m3G) structure (Mattaj 1986). The tri-methyl cap and the
Sm  complex  are  nuclear  localization  signals  that  cause  snRNPs  to  be  subsequently  re-
imported into the nucleus (Fischer and Lührmann 1990, Fischer et al. 1993). Nuclear import
is mediated by the import adapter snurportin1 (Huber et al. 1998). SMN protein interacts with
snurportin1 and is imported into the nucleus in complex with snRNPs (Narayanan et al. 2002,
Narayanan et al. 2004). After nuclear re-import, snRNPs acquire their specific proteins and
are internally modified by pseudouridylation and 2'-O-methylation by a mechanism guided by
small  RNAs  (Yu et  al. 2001).  Some  controversy  remains  over  the  location  of  these
modifications. Newly assembled snRNPs accumulate in subnuclear organelles termed Cajal
bodies  (coiled  bodies),  where  small  Cajal  body-specific  RNAs  that  guide  snRNA
modifications  are  also enriched  (Sleeman and Lamond 1999,  Jády et  al. 2003).  Also the
nucleolus has been suggested as the site of further processing (Yu et al. 2001). Cajal bodies
may also be the sites of assembly and recycling of the U4/U6.U5 tri-snRNP  (Stanek et al.
2003, Schaffert et al. 2004). Mature snRNPs are enriched in interchromatin granule clusters
aka speckles, which are believed to be storage sites for splicing factors  (Matera and Ward
1993; reviewed by Lamond and Spector 2003).
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The  final  step  in  the  maturation  of  spliceosomal  snRNPs  is  the  formation  of
preassembled snRNP complexes. The major snRNPs U4 and U6 interact by base pairing to
form the U4/U6 complex and associate with U5 by protein interactions forming the tri-snRNP
U4/U6.U5 (Bringmann et al. 1984, Hashimoto and Steitz 1984, Cheng and Abelson 1987,
Konarska  and  Sharp  1987).  The  minor  spliceosome  tri-snRNP  U4atac/U6atac.U5  forms
similarly (Tarn and Steitz 1996a, Tarn and Steitz 1996b). In addition, U11 and U12 associate
to form a di-snRNP (Montzka and Steitz 1988, Wassarman and Steitz 1992b).
1.8.2 Biogenesis of U6 and U6atac
The biogenesis of U6 and presumably U6atac snRNPs differs from that of the other
spliceosomal snRNPs. U6 is transcribed by the RNA polymerase III (Kunkel et al. 1986) and
is  believed  not  to  be  exported  from  the  nucleus.  The  polyuridine  tail  of  nascent  U6  is
transiently bound and stabilized by the La protein  (Rinke and Steitz 1985, Pannone et al.
1998). The triphosphate cap is modified into a gamma-monomethyl phosphate cap (Shimba
and  Reddy  1994).  As  the  other  spliceosomal  snRNAs,  U6  is  also  modified  by
pseudouridylation and 2'-O-methylation by small nucleolar RNPs, probably in the nucleolus
(Tycowski et  al. 1998).  U6  and  U6atac  lack  an  Sm  binding  site  and  instead,  they  are
assembled with seven Sm-like proteins, the Lsm2-8 complex, which replaces the La protein
and serves also as a nuclear retention/localization signal (Achsel et al. 1999, Schneider et al.
2002, Spiller et al. 2007).
1.9 Spliceosomal catalysis and assembly
1.9.1 Spliceosomal catalysis
Splicing is achieved by two phosphoryl transfer reactions (Padgett et al. 1984, Ruskin
et al. 1984, Maschhoff and Padgett 1993, Moore and Sharp 1993). First, the 2′ hydroxyl of the
branch site nucleotide attacks the phosphate at the 5′ splice site, producing a free 5′ exon and
an intermediate composed of the 3' exon and a lariat intron. In the second reaction, the 3′
hydroxyl of the 5′ exon attacks the phosphate at the 3′ splice site, yielding a ligated mRNA
and a lariat intron. These reactions conserve the energy of the phosphate bonds and do not
require external energy input.
It  is  likely that  splicing reactions are catalyzed by RNA, making the spliceosome a
ribozyme  (Kruger et  al. 1982,  Cech  1986;  reviewed by  Valadkhan  2007).  The  theory  is
corroborated by several lines of evidence. The structures formed by the RNA molecules in the
catalytic core of the spliceosome resemble the conformation of self-splicing group II introns.
U6 snRNA is situated in the catalytic core and coordinates metal ions (Yean et al. 2000). U2
and U6 snRNAs are capable of catalyzing a splicing-like reaction free of proteins  in vitro
(Valadkhan and Manley 2001, Valadkhan et al. 2009). The requirement for a vast number of
proteins  in  the  spliceosome  despite  RNA-based  catalysis  is  thought  to  serve  to  maintain
unidirectionality of the reactions, increase fidelity and speed and provide flexibility needed in
alternative splicing.
The similarity of the splicing mechanisms and catalytic core structures of self-splicing
group II introns with those of the spliceosome has promoted the hypothesis that spliceosomal
introns have evolved from self-splicing introns (Sharp 1985, Toor et al. 2008). According to
this theory, the spliceosome has originated through the dispersion of the self-splicing intron
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ribozyme core into several small RNAs (Jarrell et al. 1988, Sharp 1991). Further support for
the model is provided by the ability of the catalytic domain of a self-splicing group II intron to
functionally replace the metal binding stem loop in U6atac (Shukla and Padgett 2002). With
its  most  likely  RNA-based  catalytic  mechanism,  the  spliceosome  is  an  RNP  machine,
reminiscent of an ancient 'RNA world' before proteins took over most enzymatic functions in
cells.
1.9.2 U2-type spliceosome assembly
The assembly pathway of the major spliceosome is conserved from yeast to mammals.
In  the stepwise assembly  model,  the  assembly  of  the  major  spliceosome begins  with the
recognition of the splicing consensus sequences by U1 snRNP and protein factors, with U1
snRNA base pairing to the 5’ splice site, SF1 (splicing factor 1) binding to the branch point
sequence and the U2AF subunits 65K and 35K to the polypyrimidine tract and the 3' splice
site region, respectively, forming the E (early) complex (Mount et al. 1983, Black et al. 1985,
Zamore and Green 1989, Abovich and Rosbash 1997; for review, see  Staley and Guthrie
1998, Smith et al. 2008). On yeast introns, which lack a polypyrimidine tract, the analogous
commitment complex is assembled through the recognition of the 5' splice site by U1 snRNP
and  the  branch  region  by  the  SF1  orthologue  BBP  and  the  U2AF  orthologue  Mud2p
(Berglund et  al. 1997,  Abovich  and  Rosbash  1997,  Merendino et  al. 1999,  Zorio  and
Blumenthal 1999). SF1 and U2AF-35, together with SR  proteins, are involved in bridging the
intron  ends  by  protein  interactions.  Complex  A,  or  prespliceosome,  is  formed  by  the
replacement of SF1 by U2 snRNP, which binds the branch point with protein-protein and base
pairing interactions, bulging the branch site adenosine out of the duplex (Parker et al. 1987,
Query et  al. 1994).  The  stable  binding  of  U2  requires  ATP hydrolysis.  The  next  stage,
complex B, is formed upon the entry of the U4/U6.U5 tri-snRNP. Rearrangements of both
RNA-RNA and protein interactions result in the expelling of U4 snRNP, the replacement of
U1 by U6 at the 5' splice site and the formation of the catalytic core by U2 and U6 in the
activated complex B* (Konarska and Sharp 1987, Sawa and Abelson 1992, Wassarman and
Steitz  1992a).  This  reorganization  is  propelled  by  ATP-hydrolyzing  proteins  with  RNA
helicase activity (reviewed by  Staley and Guthrie 1998). U6 forms two base paired helices
with U2, bringing the 5' splice site and the branch point into close proximity for the first step
of splicing (Hausner et al. 1990, Madhani and Guthrie 1992). U5 contacts the 5' splice site on
the exon side and the 3' splice site and helps align the exons following the first step of splicing
(Newman and Norman 1992, Sontheimer and Steitz 1993). The protein composition of the
activated spliceosome is also remodelled at this stage (Makarov et al. 2002). The next stage,
complex C, contains splicing intermediates subsequent to the first step of splicing reactions.
The  sequential  recognition  of  each  splicing  signal  by  several  components  contributes  to
splicing fidelity.
In vitro, spliceosome assembly occurs in the above described stepwise manner. Some
reports  suggest  that  the  spliceosome  may  exist  as  a  preassembled  complex.  Complexes
consisting of all five spliceosomal snRNPs have been isolated in yeast and HeLa cell nuclear
extracts (Stevens et al. 2002, Malca et al. 2003). However, a preformed penta-snRNP is not a
prerequisite for splicing in vitro (Behzadnia et al. 2006).
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1.9.3 U12-type spliceosome assembly
The  assembly  pathway  of  the  U12-dependent  spliceosome  resembles  the  major
spliceosome, and interactions are functionally conserved  (Kolossova and Padgett 1997, Yu
and  Steitz  1997,  Incorvaia  and  Padgett  1998;  see  Figure  5).  However,  the  initial  intron
recognition steps differ from those involving major introns. Unlike U1 and U2 in the major
spliceosome, U11 and U12 snRNPs form a di-snRNP and recognize the 5' splice site and
branch point cooperatively  (Frilander and Steitz 1999). The base pairing interactions of U1
with the 5' splice site in the major spliceosome span nucleotides -1 to +6 relative to the 5'
splice site, whereas U11 base pairs only to positions +4 to +8. The three first nucleotides of
the  5'  splicing  consensus  are
recognized by one of the proteins
specific  to  the  U12-type
spliceosome,  the  U11-48K
protein  (Turunen et  al. 2008).
Similarly to  the assembly of  the
major  spliceosome,  the  activated
B complex is formed through the
entry  of  the  tri-snRNP
U4atac/U6atac.U5,  dissociation
of  U11  and  U4atac  and  base
pairing of  U6atac with U12 and
the 5’ splice site (Tarn and Steitz
1996a,  Yu  and  Steitz  1997,
Frilander  and  Steitz  2001).
Important  molecular  structures
and  interactions  are  also
conserved,  as  can  be  deduced
from the preservation of splicing
activity  when  the  conserved
intramolecular  stem  loop  in
U6atac  is  replaced  with  the
corresponding  structure  in  U6
(Shukla  and  Padgett  2001).
Furthermore,  U4atac  can  be
replaced  by  U4 if  the  necessary
base  pairing  interactions  with
U6atac  are  introduced  (Shukla
and Padgett 2004).
1.9.4 Spliceosome recycling
After the completion of splicing reactions, the spliceosome must be disassembled and
the components recycled for the next round of splicing. Several proteins have been implicated
in recycling, many of which also have a role in the initial assembly of spliceosomal snRNPs.
These  include  p110/SART3/hPrp24  and  hPrp31  (U4/U6-61K),  which  are  essential  to  the
recycling of both U4/U6 and U4atac/U6atac complexes. They are enriched in Cajal bodies,
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Figure 5. Schematic model of U12-type spliceosome assembly.
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which are suggested as the sites of tri-snRNP reassembly (Schneider et al. 2002, Stanek et al.
2003, Damianov et al. 2004, Schaffert et al. 2004, Stanek et al. 2008).
1.10 Communication with other processing systems
1.10.1 Cotranscriptional splicing
Although mRNA splicing can occur uncoupled from transcription, both U2- and U12-
type  splicing  is  normally  carried  out  or  at  least  initiated  during  transcription  (Beyer  and
Osheim 1988, Singh and Padgett 2009). Cotranscriptional processing is more efficient (Bird
et al. 2004, Das et al. 2006). The exact mechanisms of spliceosome recruitment are not well
known. In yeast, U1 is recruited to the transcript cotranscriptionally (Kotovic et al. 2003). In
metazoa,  phosphorylation  of  the  carboxy-terminal  domain  of  the  RNA  polymerase  II  is
essential for cotranscriptional splicing (Bird et al. 2004). Splicing is conducted in concert with
other post-transcriptional processing steps in a network of mutually enhancing interactions
(reviewed by Reed 2003, Moore and Proudfoot 2009). Splicing activity is enhanced by the
processing of adjacent introns, and pre-mRNA processing stimulates transcription (Fong and
Zhou 2001). Polyadenylation promotes splicing of the terminal exon, and splicing in turn
increases the rate of polyadenylation  (Niwa et  al. 1990, Niwa and Berget 1991). Nascent
transcripts  are  retained  at  the  transcription  site  until  the  removal  of  introns  has  been
completed (Custódio et al. 1999). Splicing also promotes the export of the mRNA out of the
nucleus (Chang and Sharp 1989, Valencia et al. 2008). Transgenes from which introns have
been removed often fail to be expressed (Hamer and Leder 1979). In some cases, introns can
be retained until later or even spliced in the cytoplasm of some cell types, e.g. in platelets
lacking a nucleus, or neuronal dendrites (Denis et al. 2005, Glanzer et al. 2005).
1.10.2 mRNA quality control by splicing 
Splicing also has an important function in the control of mRNA quality. Subsequent to
splicing, an exon junction complex is deposited at the site of the removed intron (Kataoka et
al. 2000, Le Hir et al. 2000). In nonsense-mediated decay, transcripts from genes that have
acquired a premature termination codon as a result of mutation are recognized based on the
presence of an EJC downstream of a stop codon and targeted to degradation (reviewed by
Conti  and  Izaurralde  2005).  EJC  formation  is  conserved  between  U2-  and  U12-type
spliceosomes  (Hirose et  al. 2004).  Failure  to  splice  an  intron  would  then  lead  to  the
degradation of  the mRNA,  which is  believed to happen to pre-mRNAs with inefficiently
spliced U12-type introns.
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2 Aims of the study
This work focuses on the specific characteristics of the U12-type spliceosome, in which
its function differs from the U2-type system. In particular, the low efficiency of U12-type
splicing  is  believed  to  have  important  consequences  to  gene  expression  by  limiting  the
production of mature mRNAs from genes containing U12-type introns.
The inefficiency of U12-type splicing has been attributed to the low abundance of the
components of the U12-type spliceosome in cells, but this hypothesis has not been proven.
The  aim of  the  first  part  of  this  work  was  to  study  the  effect  of  the  abundance  of  the
spliceosomal snRNA components on splicing. U4atac snRNA was chosen as the target based
on previous reports,  which led to the hypothesis that U4atac levels might be limiting the
activity of the U12-type spliceosome.
The inefficiency of U12-type splicing has also promoted the idea that the U12-type
spliceosome controls gene expression, limiting the mRNA levels of some U12-type intron-
containing genes. While the identities of the primary target genes are relatively well known,
little has previously been known about the downstream genes and pathways possibly affected
by this regulation. Splicing mutant  Drosophila was studied with the aim of screening the
effects of impaired U12-type splicing to the transcriptome of a whole organism.
The subcellular localization of the U12-type spliceosome was studied with the aim of
settling a recent dispute on whether U12-type splicing would be localized in the cytoplasm.
The answer to this fundamental question was crucial to the field.
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3 Materials and methods
Methods used in this study are listed in Table 2. For a detailed description of methods,
see the original publications.
Table 2. Methods used in this work.
Method Article
Cell lines and culture I, II
Fly strains III
Expression plasmids I
RNA isolation I, II, III
Northern blotting I, II, III
Native gel analysis I
Psoralen cross-linking I
RT-PCR I, III
Quantitative RT-PCR I, III
Nonradioactive in situ hybridization II






4 Results and discussion
4.1 The abundance of U12-dependent spliceosome components does not limit
endogenous splicing efficiency (I)
4.1.1 U4atac is the limiting component in the formation of U4atac/U6atac complex
The efficiency of U12-type splicing has been observed to be lower than normal splicing
in vitro and in vivo on transfected constructs (Patel et al. 2002). The inefficiency of U12-type
splicing has been attributed either to the low abundance of U12-type spliceosome components
or  to  a  slow  rate  of  catalysis.  In  this  study,  the  former  hypothesis  was  addressed.  The
expression levels of spliceosomal snRNAs in mouse NIH-3T3 and L-929 and human HeLa
cell lines were studied by Northern blotting. Large variation in the expression levels of U4atac
snRNA between different cell lines suggested that its levels could be regulated, while the
levels of the other snRNAs did not exhibit much variation. Therefore it was of interest to find
out whether changes in U4atac levels would have an effect on the formation of spliceosomal
higher-order  complexes  and  eventually  on  splicing  efficiency.  Since  U4atac  and  U6atac
apparently are the only components of the U4atac/U6atac.U5 tri-snRNP that are specific to
the U12-type spliceosome (Schneider et al. 2002), and the components shared with the major
spliceosome  are  much  more  abundant,  we  hypothesized  that  U4atac  may  also  limit  the
abundance  of  the  minor  tri-snRNP.  If  so,  U4atac  levels  could  directly  influence  splicing
efficiency. At least  in vitro, the intron recognition steps prior to tri-snRNP entry are faster
than the following events leading to spliceosome activation (Tarn and Steitz 1996a, Tarn and
Steitz 1996b, Frilander and Steitz 1999, Frilander and Steitz 2001), which suggests that the
bottleneck of U12-type splicing occurs at this stage. On the other hand, in vitro splicing may
not accurately reflect the situation in vivo.
To  test  the  hypothesis  that  U4atac  levels  regulate  the  activity  of  the  U12-type
spliceosome by limiting the amount of U4atac/U6atac complex, we studied a derivative of the
mouse fibroblast cell line 3T3, dubbed 3T3-D1, in which the level of U4atac snRNA was
reduced 5-fold compared to other cell lines tested, including L-929 cells that were used as
control. Nuclear extract was prepared from 3T3-D1, L-929 and HeLa cell lines and RNA was
isolated in conditions that preserved the base pairing between U6atac and U4atac. Samples
were then analyzed on native gels followed by Northern blotting. Plenty of free U6atac not
bound to U4atac was detected but the amount of free U4atac was negligible, also in cells
containing normal U4atac levels. The U4atac/U6atac complex was reduced in 3T3-D1 cells,
corresponding to the reduction in U4atac level. Therefore, U4atac is the limiting component
in  the  formation  of  the  U4atac/U6atac  di-snRNA.  The  identities  of  the  snRNAs  in  the
complex were confirmed by RNA crosslinking analysis on nuclear extracts from the same cell
lines.
4.1.2 Low U4atac levels inhibit splicing of a transfected construct
The effect of U4atac levels on splicing efficiency was studied using a splicing reporter
construct, which consisted of a part of the mouse smE gene, containing one U12-type and one
U2-type intron, fused with a fluorescent protein-coding sequence. The reporter was transiently
transfected  into  3T3-D1  cells,  which  have  low  U4atac  levels,  and  control  L-929  cells.
Unspliced reporter pre-mRNA was detected by Northern blotting in 3T3-D1 cells, whereas
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splicing in control cells was more efficient. The results were confirmed by RT-PCR, in which
two products were detected. A large product corresponding to a reporter pre-mRNA with an
unspliced U12-type intron and a correctly spliced normal intron was strongly amplified from
the 3T3-D1 sample, but only weakly from the control sample. In contrast, a smaller product
corresponding to the fully spliced mRNA dominated in control samples but was weaker in
3T3-D1. The identities of the PCR products were confirmed by cloning and sequencing.
To  test  whether  the  differences  in  splicing  were  due  to  U4atac  abundance,  we
constructed a U4atac overexpression plasmid that contained the promoter of the mouse U12
snRNA gene fused to the coding part and downstream transcription terminator sequence of
the  U4atac  gene.  The  splicing  reporter  was  cotransfected  together  with  the  U4atac
overexpression  construct  into  3T3-D1  and  control  cells  and  splicing  was  analyzed  by
Northern blotting and RT-PCR as above. Splicing of the reporter  construct  was markedly
improved in 3T3-D1 cells. In control cells, a slight decrease in the signal from the unspliced
pre-mRNA and an increase in the fully spliced mRNA were observed. The abundance of
U4atac snRNA may thus limit the activity of the U12-type spliceosome in a situation where
cells with low U4atac levels are burdened with high expression of U12-type introns.
4.1.3 Splicing of endogenous introns is not limited by U4atac levels
To find out whether U4atac levels have an effect on the splicing of endogenous genes,
selection was applied on 3T3-D1 and L-929 cells transfected with the U4atac overexpression
construct  to  obtain stably transfected cells.  Normal  function of  the  overexpressed U4atac
snRNA was confirmed by the isolation and native gel analysis of snRNA complexes from
transfected cells.  Overexpressed U4atac behaved similarly to the  endogenous snRNA and
incorporated into the U4atac/U6atac complex, which was increased approximately 5-fold in
3T3-D1 cells. This was approximately equal to the amount of the complex in untransfected
control cells.
The splicing efficiency of endogenous U12-type introns was measured by quantitative
RT-PCR  (qRT-PCR)  in  3T3-D1  and  control  cells  with  and  without  stable  U4atac
overexpression. We chose a set of genes, pex16, drap1, ipo4, psmc4, gars and smE, each with
a U12-type intron representing either GT-AG or AT-AC subtypes and ranging from 85 to
1172 nt in length. Primers were designed for one U12-type and one U2-type intron in each
gene so that 'intron' primers amplified a sequence across the exon-intron boundary, and one of
the primers in each 'exon' primer pair  spanned the exon-exon junction. The proportion of
unspliced U12-type intron-containing pre-mRNA relative to spliced mRNA varied from less
than 1% to 40% between genes, but a significant difference between 3T3-D1 and L-929 cells
was observed only with pex16, which was spliced very inefficiently in 3T3-D1 cells. U4atac
overexpression modestly decreased the U12-type intron signal from all genes tested in both
3T3-D1 and control cells, but had no effect on the levels of mature mRNA. We conclude that
the abundance of the spliceosomal components has no significant effect on endogenous gene
expression in normal situations.
4.1.4 U12-type introns are spliced less efficiently than normal introns
According to the qRT-PCR analysis of the six genes in 3T3-D1 and L-929 cells, the
signal from the unspliced U12-type intron was consistently 2- to 3-fold higher than from the
U2-type intron except for  psmc4, which was spliced inefficiently at both U12-type and U2-
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type junctions in L-929 cells. Thus, U12-type introns appear to be spliced less efficiently than
normal introns. To find out whether expression levels correlate with splicing efficiency, we
measured the levels of the mRNAs analyzed above by qRT-PCR. They exhibited 30-fold
variation between genes, but no significant correlation was observed between expression level
and splicing efficiency. 
Also  other  reports  (Patel et  al. 2002) show  that  the  U12-type  spliceosome  is  not
saturated by the expression of transfected U12-type introns at high levels. In this light, the
presence of unspliced introns in normal cells is puzzling. The situation may vary between
different cell types and tissues. It is also possible that we did not detect an effect of elevated
U4atac level on splicing because transfected cells expressed U4atac at variable levels. The
function of U4atac is to sequester U6atac until needed, and high U4atac levels might even be
inhibitory to splicing. Yet another explanation to our results is that at elevated U4atac levels,
some  other  component  of  the  U12-type  spliceosome  becomes  limiting.  The  phenomenon
could also be explained by the ability of the U12-type spliceosome to respond to a higher
demand,  perhaps by detection of  the amount  of  free components not  engaged in  splicing
reactions in the nucleoplasm.
According to a recent report by Singh and Padgett (2009), U12-type introns are spliced
almost  as  quickly  after  transcription  as  U2-type  introns;  normal  introns  were  spliced
approximately 5 minutes after transcription, and the lag time for U12-type introns was only
twice as much. However, this experiment measured only the first appearance of the spliced
product; it did not assess the average splicing rate. In the light of our data and other reports
(see  4.1.1)  detecting  inefficient  U12-type  splicing  both  in  vitro and  in  vivo in  various
metazoan systems, it is likely that U12-type introns can serve to limit gene expression levels.
4.2 Deficient U12-type splicing causes perturbations in metabolic gene
expression in Drosophila (III)
4.2.1 U6atac-deficient larvae die at 3rd larval stage
To find out more about the genes and pathways possibly affected by the regulation of
U12-type splicing activity, we investigated the effects of a U12-dependent splicing defect in a
whole organism. We chose the fruit fly as a model organism because it has only about 20
U12-type introns, which yet exhibit a similar preference to reside in information processing
genes as in mammals (Schneider et al. 2004, Alioto 2007). Most Drosophila U12-type introns
have an orthologue in mammals  (Lin et  al. 2010). Further benefits  of the fly as a model
organism  are  provided  by  the  readily  available  genetic  tools,  particularly  mutant  strain
collections.
We studied a fly strain deficient in U12-type splicing as described previously by Otake
et al. (2002). This strain has a P-element-based transposon insertion in the gene coding for
U6atac snRNA. In homozygotes,  the mutation causes impaired U12-type splicing and the
death of larvae at the 3rd larval instar. We began by studying the expression of wild-type and
mutant U6atac in larvae by Northern blotting. As detected earlier by Otake et al. (2002), wild
type U6atac snRNA was still present in 1st and 2nd instar homozygous larvae as maternal
contribution, but by the 3rd instar, it disappeared and the expression of the mutant form was
increased. It is not clear why the mutant U6atac was almost absent in heterozygotes. The
mutated snRNA may be unable to compete with wild type U6atac on the binding of snRNP
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proteins, thus becoming unstable. Heterozygous larvae had normal levels of wild type U6atac
and a normal phenotype, so we used them as control samples in our experiments.
Analysis of the mutation phenotype was complicated by the location of the U6atac gene
inside the intron of another gene, CG13394. The 10.7 kb transposon element inserted in the
U6atac gene disturbed splicing of the host gene mRNA and prevented the inclusion of the
alternative exon downstream. To assess the effect of the change in CG13394 expression on
the U6atac mutation phenotype, we studied another mutant line, which contains a transposon
element insertion in the first exon of CG13394. This line is viable and has a normal phenotype
as a homozygote. We performed microarray analysis on the host gene mutant (as in 4.2.2) and
detected no significant expression changes in any genes including the mutated gene. RT-PCR
analysis on the chimeric sequences of the mutant CG13394 gene showed that the transcription
of CG13394 was not disturbed by the insertion mutation. Therefore, we conclude that the
U6atac mutant phenotype is due to the disruption of U6atac function.
4.2.2 Genes with a U12-type intron show variable responses to defective splicing
Microarray analysis was conducted using a custom-designed cDNA array provided by
Agilent Technologies. The array contained a 60 nt probe for most Drosophila exons annotated
in the Ensembl database, excluding some very short or low-complexity exons. Samples were
total RNA from 1st, 2nd and 3rd instar homozygous and heterozygous larvae.
Initial analysis indicated 2, 62 and 632 significantly changed genes in the 1st, 2nd and
3rd instar, 1, 23 and 416 of which were downregulated, respectively, at confidence level p <
0.01. Progressively increasing changes reflect the decline of wild-type U6atac levels in the
homozygous mutant during larval development.
Genes containing a U12-type intron exhibited variable responses to the splicing defect.
Of  the  19  documented  U12-type intron-containing genes  studied,  five  showed  significant
upregulation of at least one probe in any larval stage, two had at least one downregulated
probe and the remaining 12 exhibited no significant changes. The direction of the change did
not correlate with expression level, position of the intron in the gene, or intron subtype (GT-
AG or AT-AC).  In general,  all  probes for  a given U12-type intron-containing gene were
changing in the same direction, even though for some probes, the change did not exceed the
chosen threshold of significance. Possible changes in the splicing patterns of U12-type intron
genes  were  studied  on  the  level  of  individual  exons.  However,  we  did  not  detect  any
consistent effects on exon inclusion in the vicinity of U12-type introns.
The results  for three U12-type intron-containing genes were confirmed by RT-PCR.
FBgn0085478,  FBgn0028703 (Nhe3)  and FBgn0010551,  were  upregulated,  nonsignificant
and downregulated,  respectively,  according to  array results.  With  RT-PCR using  primers
flanking a U12- or U2-type intron, accumulation of the unspliced U12-type intron signal was
seen in each case in homozygous U6atac mutant, accompanied by a decrease in the level of
spliced  mRNA.  The  control  amplicons  across  normal  introns  in  FBgn0085478  and
FBgn0028703 showed a modest  upregulation,  whereas  FBgn0010551 control  was slightly
decreased, consistent with the array results.
In the case of U12-type intron-containing genes, upregulation of the array signal can be
attributed to the accumulation of unspliced pre-mRNA and not to an increase in the level of
fully spliced mRNA. On the other hand, according to RT-PCR, fully spliced mRNAs were
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still present even in 3rd instar larvae. This is probably due to residual activity of the mutated
U6atac in splicing, but could also result from trace amounts of maternal wild-type U6atac, or
perhaps  adjustment  of  the  half-lives  of  the  mRNAs  to  maintain  their  levels  in  spite  of
defective splicing. Thus, the levels of fully spliced mRNAs from upregulated U12-type intron
genes are likely to be close to normal or modestly reduced in mutant larvae.  In contrast,
downregulation reflects true changes in mRNA levels. The variable responses of U12-type
intron genes to the splicing defect may reflect differences in their susceptibility to expression
level control by the U12-type splicing activity level. The downregulated mRNAs are most
likely targeted to degradation as the result of inefficient splicing, whereas the other U12-type
intron-containing genes may not be as sensitive to changes in splicing efficiency.
4.2.3 Downstream effects in U12-type splicing mutant may involve a mitochondrial
defect
We then focused our attention on the downregulated genes to obtain clues on how the
downstream  effects  could  be  explained.  FBgn0010551  (l(2)03709),  the  most  strongly
downregulated U12-type intron gene, exhibited mild nonsignificant downregulation already at
the first larval instar, suggesting that it was among the first genes that changed expression in
the  mutant  larvae.  FBgn0010551  is  the  fly  homologue  of  prohibitin  (PHB)  2,  a  nuclear
encoded  mitochondrial  protein  conserved  throughout  eukaryotes.  Together  with  PHB1,  it
forms the PHB complex, which has been suggested to function as a membrane-associated
chaperone/holdase,  stabilizing  unfolded  proteins  in  the  mitochondrial  inner  membrane
(Nijtmans et al. 2000, reviewed by Artal-Sanz and Tavernarakis 2009). Disruption of the PHB
complex has been found to cause mitochondrial defects in yeast. In multicellular organisms,
the PHB complex is essential for development, and prohibitin depletion causes disruption of
mitochondrial  morphology  in  C. elegans (Artal-Sanz et  al. 2003,  Van Aken et  al. 2007,
Merkwirth and Langer 2009). Consistent with its important role, FBgn0010551 is an essential
gene in Drosophila (Spradling et al. 1999).
Gene ontology term analysis on the array results pointed towards effects on pathways
related  to  nucleotide,  amino  acid  and  fatty  acid  metabolism  as  well  as  a  number  of
mitochondrial genes. A separate analysis on the expression of mitochondrial genes revealed
progressive  changes  towards  the  3rd  instar.  To  obtain  further  evidence  on  a  possible
mitochondrial defect, we compared our data to the microarray study by Fernández-Ayala et
al. (2010).  They investigated a fly line with a mutation in  technical knockout (tko) gene,
which encodes  an  essential  mitochondrial  protein.  We did these  comparisons  to  seek for
similarities  between  our  data  and  a  mitochondrial  mutant  Drosophila,  because  prohibitin
mutants have not been screened on the whole-genome level in Drosophila. The comparisons
revealed many similarities in the two sets of data: genes related to nucleotide, amino acid and
fatty acid metabolism were implicated in both datasets.  15% of the significantly changed
genes in our analysis were changed also in the tko mutant, and approximately 70% of those
showed  change  in  the  same  direction,  which  constituted  a  statistically  highly  significant
overlap. Considering that Fernández-Ayala et al. (2010) used adult flies in their analysis, the
similarities between the two datasets are remarkable. These results suggest that mitochondrial
dysfunction  has  a  significant  role  in  the  lethality  caused  by  the  U6atac  mutation  and
strengthen the hypothesis that the Drosophila prohibitin gene homologue plays a central part
in the mutation phenotype.
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The surprising finding that genes with metabolic functions are implicated in the U12-
type  splicing  mutant  suggests  that  U12-type  splicing  efficiency  can  have  an  effect  on
fundamental  metabolic  pathways.  While  it  is  likely  that  other  U12-type  intron-containing
genes contribute to the U6atac mutant phenotype, the PHB2 homologue FBgn0010551 seems
a good candidate to explain many of the observed effects.
4.3 U12-dependent spliceosome functions in the nucleus (II)
4.3.1 The snRNA components of the U12-type spliceosome are localized in the nucleus
Since the discovery of a second spliceosome, theories have been sought to explain the
need for  two spliceosomal  systems in  complex eukaryotes.  Recently,  König et  al. (2007)
presented a provocative hypothesis that the U12-type spliceosome functions in the cytoplasm.
Their  study  was  in  contradiction  with  earlier  findings  that  have  localized  U11  and  U12
snRNAs in the nucleus of human cells  (Matera and Ward 1993) and U11 in the nucleus of
Drosophila cells  (Schneider et  al. 2004).  In  addition,  GFP-tagged U12-type  spliceosome-
specific proteins U11-35K, U11/U12-31K (also known as ZCRB1, MADP-1) and U11/U12-
65K (RNPC3) are also predominantly nuclear in Arabidopsis and human cells (Zhao et al.
2003, Lorković et al. 2005, Wang et al. 2007). The contradictory previous studies were not
addressed in the study by König et al. (2007).
We set  out  to clarify the matter by investigating the localization of all  snRNA and
protein components specific to the U12-type spliceosome. First, we studied the localization of
spliceosomal snRNAs in mouse tissues. The snRNAs U1, U2, U6, U11, U12, U4atac and
U6atac  were  detected  in  the  nuclei  of  different  mouse  tissues  by  nonradioactive  in  situ
hybridization on tissue sections using digoxigenin-labelled full-length RNA probes. In each
case, the probe signal was overlapping with nuclear Hoechst counterstaining. No differences
were observed in the localization of major and minor spliceosome snRNAs.
To confirm the results with a different detection method, the localization of U2, U12,
U4atac  and  U6atac  snRNAs  was  studied  in  mouse  brain  sections  by  radioactive  in  situ
hybridization. Also in this case, the signal from snRNAs was found overlapping with nuclear
counterstaining.
Next, we compared the subnuclear localization of U11 and U12 snRNAs to that of U2
and U4 in  human  HeLa  cells  by  fluorescent  in  situ hybridization.  Nuclear  staining  with
several more intensely stained foci, likely Cajal bodies, was observed. Again, the major and
minor  snRNAs tested showed similar  distribution.  Thus,  in  situ hybridizations  with three
different detection methods on mouse tissues and human cells indicated that spliceosomal
snRNAs are nuclear.
4.3.2 Protein and snRNA components of the U12-dependent spliceosome are detected
primarily in nuclear fractions of cells
We also tested whether cellular fractionation would corroborate the results obtained by
in situ hybridization. We prepared nuclear and cytoplasmic fractions from HeLa cells, isolated
RNA and proteins from parallel fractions and detected spliceosomal components by Northern
and  Western  blotting.  Like  U1,  U2,  U4  and  U5  of  the  major  spliceosome,  the  minor
spliceosome snRNAs U11, U12 and U4atac were strongly enriched in nuclear fractions. 5S
RNA and tRNA were detected predominantly in cytoplasmic fractions,  indicating that  the
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fractions  were  well  separated.  Both  U6 and U6atac  appeared in  nuclear  and cytoplasmic
extracts  in  approximately  equal  amounts,  which  is  surprising  but  consistent  with  earlier
reports (Fury and Zieve 1996). In the light of these results, the choice of König et al. (2007) to
compare the distribution of U6atac to that of U2 in cellular fractions seems unfortunate.
Western blot analysis indicated that the U11-specific proteins 59K, 35K and 25K are
predominantly found in the nuclear fraction, as are the snRNP-associated U1-70K, U5-15K,
U4/U6-61K, SF3a66, SF3b155 and the splicing factor SF1. In contrast, Lsm1, a component of
the cytoplasmic Lsm1-7 complex,  was detected mainly in the cytoplasmic fraction. Taken
together, the components of the U12-type spliceosome are predominantly nuclear and do not
significantly differ in their localization from their counterparts in the U2-type spliceosome.
In addition to localization data, also indirect evidence points to nuclear localization of
the U12-type spliceosome. U12-type splicing is predominantly cotranscriptional  (Singh and
Padgett  2009).  Additionally,  communication between U2-type and U12-type spliceosomes
has  been  observed  in  exon  definition  interactions  and  in  the  recruitment  of  the  major
spliceosome by U11 at the USSE element, which controls the levels of 48K and 65K proteins
(Wu and Krainer 1996, Verbeeren et al. 2010). Furthermore, inhibition of U12-type splicing
often leads to activation of cryptic U2-type splice sites (Tarn and Steitz 1996b, Turunen et al.
2008), which would have devastating effects on the expression of genes containing U12-type
introns  in vivo.  This  suggests  that  some minor  spliceosome-specific  factor(s),  most  likely
components of the U11/U12 di-snRNP, must be present at the transcription site to bind the
U12-type intron and prevent the major spliceosome from interfering.
4.3.3 The nuclear dogma still holding
What could explain the disagreement between our results and the study of König et al.
(2007)? They used locked nucleic acid oligonucleotide probes to detect snRNAs by  in situ
hybridization in zebrafish tissues and mouse fibroblasts. Each oligonucleotide contained only
one  digoxigenin  molecule.  This  may  not  be  sufficient  to  provide  enough  sensitivity  to
accurately detect the low-abundance minor snRNAs. König et al. (2007) also detected U6atac
in cytoplasmic extracts but, as noted above, the presence of U6atac (and U6) in cytoplasmic
fractions does not warrant the claim that splicing should occur outside the nucleus. The Lsm2-
8 proteins bound by both U6 and U6atac function as nuclear retention/localization signals,
and U6 injected into  Xenopus oocyte cytoplasm is imported into the nucleus  (Hamm and
Mattaj 1989, Spiller et al. 2007). No U6atac-specific proteins have been found, which makes
the  existence  of  a  mechanism resulting in  a  different  subcellular  localization for  U6 and
U6atac seem unlikely. In general, the numerous similarities in the structure, biogenesis and
function between U2-  and U12-type spliceosomes give no reason to believe that  the two
systems would differ in their subcellular localization.
As a response to criticism towards their paper  König et al. (2007),  König and Müller
(2008) raised several arguments against the reliability of our results. First, they argued that
their data were obtained in a different system (zebrafish tissues). Yet, in their report (König et
al. 2007) they extrapolated their results on a general level by offering the segregation of the
U12-type spliceosome in the cytoplasm as an explanation for the existence of two separate
spliceosomes. The range of distantly related organisms (vertebrates, Drosophila, Arabidopsis;
see  4.3.1)  in  which U12-type  spliceosome components  have  been  found  to  reside  in  the
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nucleus demonstrates that exceptions to the rule, if any existed, would be highly uncommon.
Second, König and Müller (2008) questioned the specificity of the probes used in our in situ
hybridizations since we did not include controls for probe specificity in fluorescent  in situ
hybridizations  done  on  HeLa  cells.  Nevertheless,  we  did  show control  hybridizations  on
mouse  tissue sections with sense-strand probes  for  U2 and U12,  which did not  give  any
detectable signal. König et al. (2007) used mismatch probes to demonstrate specificity of their
oligonucleotide probes. However, control probes cannot be used to prove the specificity of
cognate probes. They can only demonstrate that hybridization conditions do not introduce
false signals with any probe. In our study, we used Northern blotting to verify the specificity
of our probes (Supporting information in II). Third, König and Müller (2008) pointed out the
difficulty of  achieving a complete separation of nuclear and cytoplasmic fractions. The same
criticism can be directed towards their own fractionation experiments, in which the presence
of U6atac in cytoplasmic fractions was taken as evidence on the localization of the U12-type
spliceosome.  Considering  the  distribution  of  U6  in  cellular  fractions  (see  4.3.2),  their
conclusions were not substantiated. Fourth, König and Müller (2008) suggested that the DNA
counterstain  used  in  our  in  situ hybridizations  would  cause  problems to  specificity.  This
suspicion seems unwarranted since Hoechst staining is a commonly used procedure that has
not been reported to cause problems with in situ techniques.
Later, there have been other reports determining U12-type splicing as a nuclear event in
Xenopus laevis oocytes  (Friend et al. 2008) and human cells  (Singh and Padgett 2009). In




The existence of two spliceosomal systems in complex eukaryotes has evoked many
questions  concerning  their  differences  and  the  rationale  for  maintaining  two  distinct
spliceosomes. There is considerable evidence that U12-type introns limit the expression of
their host genes. This additional means of gene expression control raises important questions:
how is the activity of the U12-type spliceosome controlled, and which pathways and functions
are affected by the level of splicing efficiency?
The low abundance of U12-type spliceosome components has been suggested to limit
its activity. Earlier in vitro studies have shown that the slow phase of spliceosome assembly
occurs  after  intron  recognition,  before  catalytic  activation;  therefore  this  study  was
concentrated on investigating the components limiting the amount of the U4atac/U6atac.U5
tri-snRNP. The results suggested that the levels of U4atac snRNA indeed limit the formation
of the minor tri-snRNP, but no effects on the expression of endogenous genes were detected.
If  one  or  some  spliceosomal  components  are  limiting  spliceosome  activity  in  vivo,  they
probably are components of the U11/U12 intron recognition complex. On the other hand, in
cells containing normal levels of U12-type spliceosome components, the spliceosome does
not appear to be saturated even by overexpression of ectopic U12-type introns. It is possible
that earlier studies on in vitro kinetics do not accurately correlate with the situation in living
cells where splicing occurs cotranscriptionally.
The second question about  the  transcriptome-level  effects  of  low U12-type splicing
efficiency was studied here using Drosophila. Despite their small number, U12-type introns
in the fly exhibit the same preference to reside in genes involved in 'information processing'
functions as mammalian U12-type introns. These pathways have been thought to be the main
targets for regulation by U12-type splicing activity. This work suggests that regulation by
splicing  efficiency  may  affect  an  entirely  different  category  of  genes  with  fundamental
metabolic functions. In the case of  Drosophila larvae, the effects of the U12-type splicing
defect  could  potentially  be  largely  attributed  to  a  single  gene,  the  fly  homologue  of
mitochondrial  PHB2.  The  genes  targeted  by  the  rate-limiting  splicing  process  may  be
different in different tissues, developmental stages or environmental situations. The U12-type
intron in PHB2 gene is conserved from insects to vertebrates including human. It would be
interesting to know whether the genes primarily affected by changes in U12-type splicing
efficiency  in  mammals  are  similar  in  function  to  those  implicated  in  splicing  mutant
Drosophila.  Studying the primary target  genes and pathways in different organisms could
help decipher the role of the U12-type spliceosome in gene expression.
The  intriguing  question  of  why  eukaryotes  maintain  two  spliceosomal  systems  has
prompted many theories  since the  discovery of  the  U12-type spliceosome.  Unfortunately,
some  have  not  been  backed  up  by  solid  evidence,  such  as  the  idea  that  the  U12-type
spliceosome would function in  the cytoplasm.  In  this  study,  the  localization of  U12-type
spliceosome components was comprehensively investigated and found to support the dogma
of nuclear splicing. In the light of this work and other recent publications, the question of the
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